9-Jan-2026 7:30 AM CST - Business Wire Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2025. The preliminary unaudited results described in this press release are based on the most current information available to management and are subject to change until the audit of the companys 2025 financial results is completed a
5-Nov-2025 3:05 PM CST - Business Wire Evolus Reports Third Quarter 2025 Financial Results Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the third quarter ended September 30, 2025. Our third quarter results reflect double-digit growth despite the current market environment. Our continued above market performance and disciplined expense management, create an important transition point for the company, as we continue to expec
28-Oct-2025 7:00 AM CST - Business Wire Evolus to Participate in 2025 Stifel Healthcare Conference Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference. The fireside chat will take place on Tuesday, November 11, 2025, at 11:20 AM ET. The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay
22-Oct-2025 7:00 AM CST - Business Wire Evolus to Report Third Quarter Financial Results on November 5, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. T
5-Aug-2025 3:05 PM CST - Business Wire Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the second quarter ended June 30, 2025. U.S. toxin demand softened in the second quarter, driven by reduced patient demand due to a sharp decrease in consumer sentiment which resulted in accounts purchasing lower volumes acutely felt in the final two weeks of the quarter. Despite these cha
22-Jul-2025 7:05 AM CST - Business Wire Evolus to Report Second Quarter Financial Results on August 5, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its second quarter 2025 financial results on Tuesday, August 5, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. To p
7-May-2025 3:05 PM CST - Business Wire Evolus Reports First Quarter 2025 Results Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended March 31, 2025. Coming off a record year, we enter 2025 with strong momentum, said David Moatazedi, President and Chief Executive Officer of Evolus. In our final quarter as a single-product company, we gained meaningful market share to start the year and delivered
23-Apr-2025 7:00 AM CST - Business Wire Evolus to Report First Quarter Financial Results on May 7, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. To par
16-Apr-2025 7:00 AM CST - Business Wire Evolus Announces Commercial Launch of Evolysse Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the commercial launch date for Evolysse Form and Evolysse Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse collection, scheduled for Friday, April 18th. To support the introduction, Evolus will initiate a comprehensive educational rollout beginning with a national Evolus Academy webcast for health
9-Jan-2026 7:30 AM CST - Business Wire Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2025. The preliminary unaudited results described in this press release are based on the most current information available to management and are subject to change until the audit of the companys 2025 financial results is completed a
5-Nov-2025 3:05 PM CST - Business Wire Evolus Reports Third Quarter 2025 Financial Results Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the third quarter ended September 30, 2025. Our third quarter results reflect double-digit growth despite the current market environment. Our continued above market performance and disciplined expense management, create an important transition point for the company, as we continue to expec
28-Oct-2025 7:00 AM CST - Business Wire Evolus to Participate in 2025 Stifel Healthcare Conference Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference. The fireside chat will take place on Tuesday, November 11, 2025, at 11:20 AM ET. The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay
22-Oct-2025 7:00 AM CST - Business Wire Evolus to Report Third Quarter Financial Results on November 5, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. T
5-Aug-2025 3:05 PM CST - Business Wire Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the second quarter ended June 30, 2025. U.S. toxin demand softened in the second quarter, driven by reduced patient demand due to a sharp decrease in consumer sentiment which resulted in accounts purchasing lower volumes acutely felt in the final two weeks of the quarter. Despite these cha
22-Jul-2025 7:05 AM CST - Business Wire Evolus to Report Second Quarter Financial Results on August 5, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its second quarter 2025 financial results on Tuesday, August 5, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. To p
7-May-2025 3:05 PM CST - Business Wire Evolus Reports First Quarter 2025 Results Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended March 31, 2025. Coming off a record year, we enter 2025 with strong momentum, said David Moatazedi, President and Chief Executive Officer of Evolus. In our final quarter as a single-product company, we gained meaningful market share to start the year and delivered
23-Apr-2025 7:00 AM CST - Business Wire Evolus to Report First Quarter Financial Results on May 7, 2025 Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow managements remarks. To par
16-Apr-2025 7:00 AM CST - Business Wire Evolus Announces Commercial Launch of Evolysse Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the commercial launch date for Evolysse Form and Evolysse Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse collection, scheduled for Friday, April 18th. To support the introduction, Evolus will initiate a comprehensive educational rollout beginning with a national Evolus Academy webcast for health
